Obviousness and NSDP Tests
The Federal Circuit Refines Patentability Requirements in pharmaceutical and Chemical Technologies A decision from the Federal Circuit Court of Appeals has refined what is required to show obviousness and anticipation in a pharmaceutical patent. The patent involved lacosamide, an amino acid-like drug used in epilepsy treatment, shown below: Accord, a generic drug manufacturer, submitted an […]
Read More